Viewing Study NCT04387461


Ignite Creation Date: 2025-12-24 @ 11:58 AM
Ignite Modification Date: 2026-01-02 @ 7:06 PM
Study NCT ID: NCT04387461
Status: COMPLETED
Last Update Posted: 2024-09-25
First Post: 2020-05-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin
Sponsor: CG Oncology, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CG2003C
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View